Dilara İnan
- Hepatology top 10%
- Hepatitis C virus research 9
-
- Nosocomial Infections in ICU 3
- Molecular Medicine top 10%
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions 10
- HIV/AIDS drug development and treatment 5
-
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 5
- HIV, Drug Use, Sexual Risk 4
-
- HIV Research and Treatment 8
- Co-authors
- Ata Nevzat YalçınGözde ÖngütÖzge TurhanRabin SabaErkan ÇobanDilek ÇolakFiliz GünserenDilara Öğünç
- Journals
- SHILAP Revista de lepidopterología (2 papers)Journal of Antimicrobial Chemotherapy (1 paper)Infection Control and Hospital Epidemiology (1 paper)
- Partner nations
- TürkiyeUnited StatesCyprus
In The Last Decade
Dilara İnan
34 papers receiving 450 citations
Peers
Comparison fields: 5 of 72
- Applied Microbiology and Biotechnology 101
- Hepatology 92
- Critical Care and Intensive Care Medicine 57
- Molecular Medicine 43
- Infectious Diseases 150
Countries citing papers authored by Dilara İnan
This map shows the geographic impact of Dilara İnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilara İnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilara İnan more than expected).
Fields of papers citing papers by Dilara İnan
This network shows the impact of papers produced by Dilara İnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilara İnan. The network helps show where Dilara İnan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dilara İnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2021 | 16 | |
| 3 | 2021 | 5 | |
| 4 | 2017 | 5 | |
| 5 | 2017 | 0 | |
| 6 | 2017 | 1 | |
| 7 | 2016 | 8 | |
| 8 | 2015 | 11 | |
| 9 | 2015 | 13 | |
| 10 | 2014 | 11 | |
| 11 | 2014 | 11 | |
| 12 | 2014 | 25 | |
| 13 | 2014 | 5 | |
| 14 | 2014 | 2 | |
| 15 | 2009 | 88 | |
| 16 | Seroepidemiology of fascioliasis in the Antalya region and uselessness of eosinophil count as a surrogate marker and portable ultrasonography for epidemiological surveillance. | 2006 | 18 |
| 17 | 2006 | 36 | |
| 18 | 2005 | 37 | |
| 19 | 2004 | 6 | |
| 20 | 2003 | 4 |
About Dilara İnan
Dilara İnan is a scholar working on Virology, Hepatology and Applied Microbiology and Biotechnology, having authored 38 papers that have together received 482 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (10 papers), Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers), HIV Research and Treatment (8 papers), Liver Disease Diagnosis and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers), HIV, Drug Use, Sexual Risk (4 papers) and Nosocomial Infections in ICU (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (101 citations), Hepatology (92 citations) and Critical Care and Intensive Care Medicine (57 citations). Dilara İnan has collaborated with scholars based in Türkiye, United States and Cyprus. Frequent co-authors include Ata Nevzat Yalçın, Gözde Öngüt, Özge Turhan, Rabin Saba, Erkan Çoban, Dilek Çolak, Filiz Günseren, Dilara Öğünç, Atilla Ramazanoğlu and Murat Yılmaz. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and Infection Control and Hospital Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.